AiRPaDD Advancing Reaction Platforms for Drug Discovery
- Coordinator
- Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea, Spain
- Runs
- 1 February 2023 to 31 January 2027
- Status
- Running
- EU funding
- €799k
- Total cost
- —
- Partners
- 5 organisations in 4 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101069949
What the project is doing
In the project's own words, from its summary on CORDIS.
This Action will contribute to the sustainable development of European chemical industries in the coming decades by delivering an ambitious doctoral training programme that draws on expertise from industry and academia across 4 European countries. The research agenda and experiential training will grow the skills base beyond approaches that have relied upon a limited set of molecular scaffolds and a relatively small sub-set of reactions to exploit new reaction paradigms and platforms (e.g. high throughput experimentation, photoredox & electrochemistry) that meet the needs of modern drug discovery science.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea | Leioa | Spain | Coordinator |
| Sanofi-Aventis Deutschland GmbH | Frankfurt Am Main | Germany | Participant |
| Astrazeneca AB | Sodertaelje | Sweden | Participant |
| AF ChemPharm Ltd | Sheffield | United Kingdom | Associatedpartner |
| The University of Sheffield | Sheffield | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI